The North America Meningococcal Vaccine Market would witness market growth of 7.8% CAGR during the forecast period (2020-2026). Meningococcal meningitis is one of the rarest bacterial infections of the brain but it is potentially devastating in nature. Despite the advancement in the healthcare sector, still more R&D is required to be done as this disease can kill the host in a very short span. One out of 10 meningococcal meningitis patients expire from the disease, and about 15% of the survivors may suffer from some deadly complications, such as brain damage, amputation, or/and deafness.
The first attempt for the development of vaccines against meningitis was taken in the early 1900s and it had variable degrees of success. For the first time in the 1930s, a safe, stable, and effective vaccines were developed against pneumococcal meningitis, and following this in the 1960s, vaccines against meningococcal meningitis produced. Since then, researchers are focused on creating more effective and efficient vaccines against the numerous bacterial that causes meningitis.
Still, there is no single vaccine which is capable of fighting all forms of meningitis, that is why over past few years, research, and development for potential vaccines has grown considerably. There is notable decline in the occurrence of bacterial meningitis, 90% of the reduction in the disease is due to the increasing use of vaccination.
Meningococcal vaccines are perceiving a significant demand in line with a prominent increase in routine immunization. Increasing use of meningococcal vaccines for immunizing special risk groups, such as travellers, or military personnel is fuelling gains in the market.
Based on Brand, the market is segmented into Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands. Based on Type, the market is segmented into Bivalent, Quadrivalent and Other Types. Based on Age Group, the market is segmented into Infants (0 to 2 years) and Children (2 years & above). Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Meningococcal Vaccine Market in North America is expected to register a CAGR of 7.8% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Scope of the Study
Market Segments Covered in the Report:
By Brand
- Bexsero
- Trumenba
- Nimenrix
- Menactra
- Menveo
- Other Brands
By Type
- Bivalent
- Quadrivalent
- Other Types
By Age Group
- Infants (0 to 2 years)
- Children (2 years & above)
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Sanofi S.A.
- Walvax Biotechnology Co., Ltd.
- Bio-Manguinhos (Oswaldo Cruz Foundation)
- Bio-Med Pvt. Ltd.
- Chongqing Zhifei Biological Products Co., Ltd.
- Hualan Biological Engineering, Inc.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Meningococcal Vaccine Market, by Brand
1.4.2 North America Meningococcal Vaccine Market, by Type
1.4.3 North America Meningococcal Vaccine Market, by Age Group
1.4.4 North America Meningococcal Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Developments in Meningococcal Vaccine Market
Chapter 4. North America Meningococcal Vaccine Market by Brand
4.1 North America Bexsero Market by Country
4.2 North America Trumenba Market by Country
4.3 North America Nimenrix Market by Country
4.4 North America Menactra Market by Country
4.5 North America Menveo Market by Country
4.6 North America Other Brands Market by Country
Chapter 5. North America Meningococcal Vaccine Market by Type
5.1 North America Bivalent Market by Country
5.2 North America Quadrivalent Market by Country
5.3 North America Other Types Market by Country
Chapter 6. North America Meningococcal Vaccine Market by Age Group
6.1 North America Children (2 years & above) and Adults Market by Country
6.2 North America Infants(0 to 2 years) Market by Country
Chapter 7. North America Meningococcal Vaccine Market by Country
7.1 USA Meningococcal Vaccine Market
7.1.1 USA Meningococcal Vaccine Market by Brand
7.1.2 USA Meningococcal Vaccine Market by Type
7.1.3 USA Meningococcal Vaccine Market by Age Group
7.2 Canada Meningococcal Vaccine Market
7.2.1 Canada Meningococcal Vaccine Market by Brand
7.2.2 Canada Meningococcal Vaccine Market by Type
7.2.3 Canada Meningococcal Vaccine Market by Age Group
7.3 Mexico Meningococcal Vaccine Market
7.3.1 Mexico Meningococcal Vaccine Market by Brand
7.3.2 Mexico Meningococcal Vaccine Market by Type
7.3.3 Mexico Meningococcal Vaccine Market by Age Group
7.4 Rest of North America Meningococcal Vaccine Market
7.4.1 Rest of North America Meningococcal Vaccine Market by Brand
7.4.2 Rest of North America Meningococcal Vaccine Market by Type
7.4.3 Rest of North America Meningococcal Vaccine Market by Age Group
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
TABLE 1 North America Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 2 North America Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 3 North America Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 4 North America Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 5 North America Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 6 North America Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 7 North America Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 8 North America Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 9 North America Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 10 North America Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 11 North America Menactra Market by Country, 2016 - 2019, USD Million
TABLE 12 North America Menactra Market by Country, 2020 - 2026, USD Million
TABLE 13 North America Menveo Market by Country, 2016 - 2019, USD Million
TABLE 14 North America Menveo Market by Country, 2020 - 2026, USD Million
TABLE 15 North America Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 16 North America Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 17 North America Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 18 North America Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 19 North America Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 20 North America Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 21 North America Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 22 North America Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 23 North America Other Types Market by Country, 2016 - 2019, USD Million
TABLE 24 North America Other Types Market by Country, 2020 - 2026, USD Million
TABLE 25 North America Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 26 North America Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 27 North America Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 28 North America Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 29 North America Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 30 North America Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 31 North America Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 32 North America Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 33 USA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 34 USA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 35 USA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 36 USA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 37 USA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 38 USA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 39 USA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 40 USA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 41 Canada Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 42 Canada Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 43 Canada Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 44 Canada Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 45 Canada Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 46 Canada Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 47 Canada Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 48 Canada Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 49 Mexico Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 50 Mexico Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 51 Mexico Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 52 Mexico Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 53 Mexico Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 54 Mexico Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 55 Mexico Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 56 Mexico Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 57 Rest of North America Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 58 Rest of North America Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 59 Rest of North America Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 60 Rest of North America Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 61 Rest of North America Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 62 Rest of North America Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 63 Rest of North America Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 64 Rest of North America Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 65 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 66 Key Information – Pfizer, Inc.
TABLE 67 Key Information – Sanofi S.A.
TABLE 68 Key Information – Walvax Biotechnology Co., Ltd.
TABLE 69 Key Information – Bio-Manguinhos
TABLE 70 key information – Bio-Med Pvt. Ltd.
TABLE 71 key Information – Chongqing Zhifei Biological Products Co., Ltd.
TABLE 72 Key Information – Hualan Biological Engineering, Inc.
TABLE 73 key information – Incepta Pharmaceuticals Ltd.
TABLE 74 Key Information – Serum Institute of India Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research